Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support.

Judita SzkukalekRóbert DócziAnna DirnerÁkos BoldizsárÁgnes VargaJúlia DériDóra LakatosDóra TihanyiBarbara VodicskaRichárd SchwábGábor PajkosEdit VárkondiIstván Vályi-NagyDorottya ValtinyiZsuzsanna NagyIstvan Petak

Published in: Diagnostics (Basel, Switzerland) (2021)

Deployment of precision oncology using liquid biopsy, comprehensive molecular profiling, and DDA make personalized first-line therapy of advanced pNET feasible in clinical settings.

Keyphrases

ultrasound guided
fine needle aspiration
ionic liquid
squamous cell carcinoma
small cell lung cancer
palliative care
single cell
stem cells
single molecule
bone marrow